Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
2(67%)
Results Posted
100%(1 trials)

Phase Distribution

Ph not_applicable
2
67%
Ph phase_2
1
33%

Phase Distribution

0

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution3 total trials
Phase 2Efficacy & side effects
1(33.3%)
N/ANon-phased studies
2(66.7%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

3

all time

Status Distribution
Active(2)
Completed(1)

Detailed Status

Recruiting1
Active, not recruiting1
Completed1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
2
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 21 (33.3%)
N/A2 (66.7%)

Trials by Status

recruiting133%
active_not_recruiting133%
completed133%

Recent Activity

2 active trials
Showing 3 of 3
recruitingnot_applicable

Molecular Imaging Informed Radiation Dose Escalation to Sites of Recurrent Disease and De-escalation to Uninvolved Areas in Salvage Radiotherapy for Prostate Cancer

NCT05328505
active_not_recruitingphase_2

Radiation Therapy to Treat Musculoskeletal Tumors

NCT00186992
completednot_applicable

Prostate Accurately Targeted Radiotherapy Investigation of Overall Treatment Time

NCT01423474

Clinical Trials (3)

Showing 3 of 3 trials
NCT05328505Not Applicable

Molecular Imaging Informed Radiation Dose Escalation to Sites of Recurrent Disease and De-escalation to Uninvolved Areas in Salvage Radiotherapy for Prostate Cancer

Recruiting
NCT00186992Phase 2

Radiation Therapy to Treat Musculoskeletal Tumors

Active Not Recruiting
NCT01423474Not Applicable

Prostate Accurately Targeted Radiotherapy Investigation of Overall Treatment Time

Completed

All 3 trials loaded

Drug Details

Intervention Type
RADIATION
Total Trials
3